The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document


CA415075833

Gene: SLC6A8
Condition: creatine transporter deficiency
Inheritance Mode: X-linked inheritance
UUID: d0f0ac0e-6cc7-4439-9e3a-fa7890baf76e
Approved on: 2023-03-23
Published on: 2024-03-29

HGVS expressions

NM_001142805.2:c.1A>G
NC_000023.11:g.153688575A>G
CM000685.2:g.153688575A>G
NC_000023.10:g.152954030A>G
CM000685.1:g.152954030A>G
NC_000023.9:g.152607224A>G
NG_012016.1:g.5279A>G
NG_012016.2:g.5279A>G
ENST00000253122.10:c.1A>G
ENST00000253122.9:c.1A>G
ENST00000458354.5:c.-3+240T>C
ENST00000480693.1:n.64+240T>C
NM_001142805.1:c.1A>G
NM_005629.3:c.1A>G
NM_005629.4:c.1A>G

Uncertain Significance

Met criteria codes 3
PVS1_Moderate PP4 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Cerebral Creatine Deficiency Syndromes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for SLC6A8 Version 1.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Cerebral Creatine Deficiency Syndromes VCEP
The NM_005629.4:c.1A>G p.(Met1Val) variant in SLC6A8 variant in SLC6A8 may cause a truncated or absent protein by altering the start codon of the coding sequence and is predicted to lead to the omission of a critical region of the protein (PVS1_Moderate). The variant was identified in a family with increased urinary creatine to creatinine ratio; additional details not provided (PMID: 23644449) (PP4). This variant is absent from gnomAD v2.1.1, therefore PM2_Supporting criteria is applicable. At the time of this curation, this variant has not been reported in individuals with suspected Creatine Transporter Deficiency in the literature. In summary, this variant meets the criteria to be classified as a Variant of Uncertain Significance for Creatine Transporter Deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel (Specifications Version 1.0): PVS1_Moderate, PP4, PM2_Supporting. (Classification approved by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel on March 23, 2023).
Met criteria codes
PVS1_Moderate
The NM_005629.4:c.1A>G p.(Met1?) variant in SLC6A8 variant in SLC6A8 may cause a truncated or absent protein by altering the start codon of the coding sequence and is predicted to lead to the omission of a critical region of the protein (PVS1_Moderate).
PP4
Identified in a family with "increased urinary Cr to Crn ratio compared with age-related references values"; additional details not provided (PMID: 23644449) (PP4).
PM2_Supporting
Variant is absent from gnomADv2.1.1 therefore PM2_Supporting criteria is applicable.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.